These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4622788)

  • 21. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 23. [The blood-sugar depressing and betacytotrope effect of glibornurid in healthy and in gastric-resected persons (author's transl)].
    Grabner W; Matzkies F; Randerbrock V; Berg G
    Med Klin; 1973 Aug; 68(34):1101-5. PubMed ID: 4598149
    [No Abstract]   [Full Text] [Related]  

  • 24. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of the association of phenformin and glibenclamide on insulin secretion in anesthetized dogs].
    Loubatières AL; Ribes G; Valette G
    C R Seances Soc Biol Fil; 1973; 167(12):1895-7. PubMed ID: 4213806
    [No Abstract]   [Full Text] [Related]  

  • 26. Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas.
    Bosco-Lévy P; Salvo F
    BMJ; 2016 Aug; 354():i4328. PubMed ID: 27495245
    [No Abstract]   [Full Text] [Related]  

  • 27. Authors' reply to Bosco-Lévy and Salvo.
    Romley JA; Gong C; Jena AB; Goldman DP; Williams B; Peters A
    BMJ; 2016 Aug; 354():i4330. PubMed ID: 27496026
    [No Abstract]   [Full Text] [Related]  

  • 28. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 29. [Influencing of blood sugar, serum insulin level and nonesterified fatty acids during continuous feeding following orally administered sulfonylurea compounds ARDF 26 and glibenclamide].
    Zilker T; Waldthaler A; Lüders T; Ermler R; Bottermann P
    Verh Dtsch Ges Inn Med; 1974; 80():1299-302. PubMed ID: 4217979
    [No Abstract]   [Full Text] [Related]  

  • 30. Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats.
    Chen B; Moore A; Escobedo LV; Koletsky MS; Hou D; Koletsky RJ; Ernsberger P
    Exp Biol Med (Maywood); 2011 Mar; 236(3):309-14. PubMed ID: 21345931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2164. PubMed ID: 4146790
    [No Abstract]   [Full Text] [Related]  

  • 33. [Insulin liberation from the pancreas by sulfonylurea].
    Pfaff W; Schöne HH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proper selection and practical administration of sulphonylurea agents to diabetics].
    Kurahachi H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():346-50. PubMed ID: 12387016
    [No Abstract]   [Full Text] [Related]  

  • 35. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hypoglycemic sulfonamides on glucagon and insulin secretion in ducks and dogs.
    Kajinuma H; Kuzuya TT; Ide T
    Diabetes; 1974 May; 23(5):412-7. PubMed ID: 4208464
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of gliquidone and glibenclamide following oral administration].
    Ziler T; Waldthaler A; Ermler R; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistological demonstration of insulin in islets of langerhans after stimulation of insulin secretion by glucose, sulphonylureas and insulin antibodies.
    Bürkle PA; Hemm G; Huber V; Federlin K
    Diabetologia; 1971 Dec; 7(6):423-30. PubMed ID: 5004177
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of calcitonin on insulin and glucagon secretion by the pancreas].
    Iaroshevskiĭ IuA; Darinskiĭ IuA; Butakova SS
    Probl Endokrinol (Mosk); 1989; 35(4):58-61. PubMed ID: 2690060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.